Novartis’ generic drug arm, Sandoz, has entered into a long-term agreement with Civica Rx to manufacture and supply critical injectable generic medicines, to help reduce supply shortages and ensure acute care settings can deliver optimal patient care.   Under the five-year agreement, Sandoz will supply six injectable medicines widely used at Civica’s 1,200 U.S. member hospitals, to help ensure patients have access to high-quality, critical medicines when needed. These include antibiotics, ...